Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ISCO > SEC Filings for ISCO > Form 8-K on 13-Jun-2013All Recent SEC Filings

Show all filings for INTERNATIONAL STEM CELL CORP | Request a Trial to NEW EDGAR Online Pro

Form 8-K for INTERNATIONAL STEM CELL CORP


13-Jun-2013

Submission of Matters to a Vote of Security Holders


Item 5.07 Submission of Matters to a Vote of Security Holders

International Stem Cell Corporation held its Annual Meeting of Stockholders on June 10, 2013. The stockholders considered four proposals, each of which is described in more detail in the Company's definitive proxy statement dated April 30, 2013.

Proposal 1: Election of six directors to hold office until the 2014 Annual Meeting:

A. Directors elected by holders of Series D Preferred Stock (voting on an as converted basis).

                                            FOR          WITHHELD
                    Andrey Semechkin     21,500,000               0
                    Ruslan Semechkin     21,500,000               0

B. Directors elected by holders of all shares of stock.

FOR WITHHELD

                   Donald A. Wright       65,954,154     496,062
                   James H. Berglund      65,923,615     526,601
                   Paul V. Maier          65,933,765     516,451
                   Charles J. Casamento   65,935,154     515,062

Broker Non-Votes: 50,238,320

All of the foregoing candidates were elected.

Proposal 2: Ratification of the selection of Mayer Hoffman McCann, P.C., as the Company's independent public accountants for the Company's fiscal year ending December 31, 2013 (shares of common stock and all series of preferred stock voting together):

FOR AGAINST ABSTAIN
112,809,341 701,518 336,278

Broker Non-Votes: none

The foregoing proposal was approved.

Proposal 3: Approval, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement (shares of common stock and all series of preferred stock voting together):

                          FOR           AGAINST    ABSTAIN
                          65,010,056   1,178,061   262,099


Broker Non-Votes: 50,238,320

The foregoing proposal was approved.

Proposal 4: Indication, on an advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers (shares of common stock and all series of preferred stock voting together):

3 Years 2 Years 1 Year Abstain 1,537,882 55,887,735 7,538,590 162,174

Broker Non-Votes: 50,238,320

Based on the stockholder vote, the Board of Directors has determined to hold future advisory votes on the compensation of the Company's Named Executive Officers every 2 years until the next stockholder advisory vote on the frequency of stockholder votes on the compensation of executive officers or until the Board of Directors otherwise determines that a different frequency for such advisory vote would be in the best interests of the stockholders.


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

International Stem Cell Corporation

By: /s/ Jay Novak
Jay Novak
Interim Chief Financial Officer

Dated: June 13, 2013

  Add ISCO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ISCO - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.